腫瘍アブレーションの世界市場:治療別(手術、経皮)、用途別(肺、肝臓癌)、技術別(高周波、マイクロ波)、セグメント予測

【英語タイトル】Tumor Ablation Market Size, Share & Trends Analysis Report By Treatment (Surgical, Percutaneous), By Application (Lung, Liver Cancer), By Technology (Radiofrequency, Microwave), And Segment Forecasts, 2018 - 2025

Grand View Researchが出版した調査資料(GVW903174)・商品コード:GVW903174
・発行会社(調査会社):Grand View Research
・発行日:2018年11月9日
・ページ数:92
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥1,176,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,472,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、腫瘍アブレーションの世界市場について調査・分析し、腫瘍アブレーションの世界市場動向、腫瘍アブレーションの世界市場規模、市場予測、セグメント別腫瘍アブレーション市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global tumor ablation market size is anticipated to reach USD 2.17 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to witness a healthy CAGR of 11.12% during the forecast period. Increasing cases of cancer across the globe is the key growth-driving factor for this market. About 13.0% of the population suffers from cancer each year, as per the statistics by the World Health Organization (WHO).
Demand for minimally invasive procedures due to the benefits, such as less trauma, speedy recovery, along with technological advancements in the field of thermal ablation is also likely to boost market growth. For instance, usage of cooled radiofrequency denervation technique – a procedure that uses radiofrequency thermal energy to ablate sensory nerve fibers of the sacroiliac joint – with internally cooled radiofrequency probes to enlarge the lesion size.

In February 2015, SonaCare Medical LLC launched Sonalink – a remote patient monitoring platform – that can be used during High-Intensity Focused Ultrasound (HIFU) procedures. In addition, increasing per capita income is enabling people to take up advanced treatment for tumors, thus driving the growth of this market. Active role of healthcare agencies and government in creating awareness about various cancer types is also expected to facilitate usage of tumor ablation therapy, thereby supporting market development.

Further key findings from the study suggest:

• Radiofrequency led the technology segment in 2017 accounting for over 30.5% of the market share as this therapy finds applications in solid tumor removal

• Percutaneous procedures are expected to witness lucrative growth over the forecast period due to rising demand for minimally invasive procedures offering faster recovery and higher safety

• Lung cancer is anticipated to witness lucrative growth in the coming years. Sedentary lifestyle and rising air pollution are contributing to growing prevalence of lung cancer

• North America led the overall tumor ablation market. Key factors driving the regional market are increasing prevalence of cancer in Canada and U.S., easy reimbursement policies, and availability of quality healthcare

• Major companies in the market include Galil Medical, Inc.; Misonix, Inc.; HealthTronics, Angiodynamics, (Covidien), Boston Scientific Corporation; Medtronic Plc; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical, Inc.

【レポートの目次】

Table of Contents

Chapter 1 Executive Summary
Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Data Analysis
2.3 Region Wise Market Calculation
2.3.1 Region Wise Market: Base Estimates
2.3.2 Global Market: CAGR Calculation
2.4 Region based segment share calculation
2.5 List of Secondary Sources (partial list)
2.6 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Rising incidence of cancer
3.2.2 Technological advancements in ablation devices
3.2.3 Increasing per capita income
3.2.4 Growing demand of minimally invasive surgeries
3.3 Market Restraint Analysis
3.3.1 Complications associated with Tumor Ablation therapy
3.3.2 Stringent regulations & approvals
3.4 Penetration & Growth Prospect Mapping: Product
3.5 Tumor Ablation Market – SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis – Porter’s
3.7 Brand Wise Pricing Analysis
Chapter 4 Regulatory Approval
4.1 Medical device classification
4.2 Framework for medical regulations
4.2.1 U.S.
4.2.2 Canada
4.3 Europe
4.4 Asia Pacific
4.4.1 Japan
4.4.2 China
4.5 Latin America
4.6 Middle East & Africa
Chapter 5 Reimbursement pathway
5.1 North America
5.2 Europe
5.3 Asia Pacific
5.3.1 China
5.3.2 Japan
5.4 Latin America
5.5 Middle East & Africa
5.5.1 South Africa
Chapter 6 Tumor Ablation Market: Technology Estimates & Trend Analysis
6.1 Tumor ablation market: Technology movement analysis
6.2 Radiofrequency ablation
6.2.1 Global radiofrequency ablation market estimates & forecasts, 2014 – 2025 (USD Million)
6.3 Microwave ablation
6.3.1 Global microwave market estimates & forecasts, 2014 – 2025 (USD Million)
6.4 Cryoablation
6.4.1 Global cryoablation market estimates & forecasts, 2014 – 2025 (USD Million)
6.5 Irreversible electroporation
6.5.1 Global irreversible electroporation market estimates & forecasts, 2014 – 2025 (USD Million)
6.6 Other ablation technologies
6.6.1 Global other ablation technologies market estimates & forecasts, 2014 – 2025 (USD Million)
Chapter 7 Tumor Ablation Market: Treatment Estimates & Trend Analysis
7.1 Tumor Ablation market: Treatment movement analysis
7.2 Surgical ablation
7.2.1 Global surgical ablation market estimates & forecasts, 2014 – 2025
7.3 Laparoscopic ablation
7.3.1 Global laparoscopic ablation market estimates & forecasts, 2014 – 2025
7.4 Percutaneous ablation
7.4.1 Global percutaneous ablation market estimates & forecasts, 2014 – 2025
Chapter 8 Tumor Ablation Market: Application Estimates & Trend Analysis
8.1 Tumor Ablation market: Application movement analysis
8.2 Liver cancer
8.2.1 Global liver cancer market estimates & forecasts, 2014 – 2025
8.3 Breast cancer
8.3.1 Global breast cancer market estimates & forecasts, 2014 – 2025
8.4 Lung cancer
8.4.1 Global lung cancer market estimates & forecasts, 2014 – 2025
8.5 Prostate cancer
8.5.1 Global prostate cancer market estimates & forecasts, 2014 – 2025
8.6 Other cancer
8.6.1 Global other cancer market estimates & forecasts, 2014 – 2025
Chapter 9 Market Share Analysis
9.1 Market share analysis: HIFU competitive analysis
9.1.1 Insightec
9.1.2 SonaCare Medical
9.1.3 EDAP
9.1.4 FUS Instruments
9.1.5 Sonic Concept
9.1.6 Haifu
Chapter 10 Regional Estimates & Trend Analysis, by Technology, Treatment, & Application
10.1 Tumor ablation market share by region, 2016 & 2025
10.2 North America
10.2.1 North America tumor ablation market estimates & forecasts, 2014 – 2025 (USD Million)
10.2.2 U.S.
10.2.2.1 U.S. Tumor ablation market, 2014 – 2025 (USD Million)
10.2.3 Canada
10.2.3.1 Canada tumor ablation market, 2014 – 2025 (USD Million)
10.3 Europe
10.3.1 Europe tumor ablation market, 2014 – 2025 (USD Million)
10.3.2 U.K.
10.3.2.1 U.K. tumor ablation market, 2014 – 2025 (USD Million)
10.3.3 Germany
10.3.3.1 Germany tumor ablation market, 2014 – 2025 (USD Million)
10.3.4 France
10.3.4.1 France tumor ablation market, 2014 – 2025 (USD Million)
10.3.5 Italy
10.3.5.1 Italy tumor ablation market, 2014 – 2025 (USD Million)
10.3.6 Spain
10.3.6.1 Spain tumor ablation market, 2014 – 2025 (USD Million)
10.3.7 Belgium
10.3.7.1 Belgium tumor ablation market, 2014 – 2025 (USD Million)
10.3.8 Switzerland
10.3.8.1 Switzerland tumor ablation market, 2014 – 2025 (USD Million)
10.3.9 Poland
10.3.9.1 Poland tumor ablation market, 2014 – 2025 (USD Million)
10.4 Asia Pacific
10.4.1 Asia Pacific tumor ablation market, 2014 – 2025 (USD Million)
10.4.2 Japan
10.4.2.1 Japan tumor ablation market, 2014 – 2025 (USD Million)
10.4.3 China
10.4.3.1 China tumor ablation market, 2014 – 2025 (USD Million)
10.5 Latin America
10.5.1 Latin America tumor ablation market, 2014 – 2025 (USD Million)
10.5.2 Brazil
10.5.2.1 Brazil tumor ablation market, 2014 – 2025 (USD Million)
10.5.3 Mexico
10.5.3.1 Mexico tumor ablation market, 2014 – 2025 (USD Million)
10.6 MEA
10.6.1 MEA tumor ablation market, 2014 – 2025 (USD Million)
10.6.2 South Africa
10.6.2.1 South Africa tumor ablation market, 2014 – 2025 (USD Million)
Chapter 11 Competitive Landscape
11.1 Company market share analysis.
11.2 Company regional market share analysis
11.2.1 Medtronic
11.2.2 AngioDynamics, Inc.
11.2.3 Galil Medical Inc. (BTG Plc.)
11.2.4 EDAP TMS S.A.
11.2.5 Boston Scientific
11.2.6 MISONIX Inc.
11.3 Strategy Framework
Chapter 12 Competitive Landscape
12.1 Company Profiles
12.1.1 Medtronic
12.1.1.1 Company overview
12.1.1.2 Financial performance
12.1.1.3 Product benchmarking
12.1.1.4 Product benchmarking
12.1.2 AngioDynamics
12.1.2.1 Company overview
12.1.2.2 Financial performance
12.1.2.3 Product benchmarking
12.1.2.4 Strategic initiatives
12.1.3 Mermaid Medical
12.1.3.1 Company overview
12.1.3.2 Financial performance
12.1.3.3 Product benchmarking
12.1.4 HealthTronics, Inc.
12.1.4.1 Company overview
12.1.4.2 Financial performance
12.1.4.3 Product benchmarking
12.1.4.4 Strategic initiatives
12.1.5 Galil Medical, Inc.
12.1.5.1 Company overview
12.1.5.2 Financial performance
12.1.5.3 Service benchmarking
12.1.5.4 Strategic initiatives
12.1.6 EDAP TMS
12.1.6.1 Company overview
12.1.6.2 Financial performance
12.1.6.3 Product benchmarking
12.1.6.4 Strategic initiatives
12.1.7 Boston Scientific Corporation
12.1.7.1 Company overview
12.1.7.2 Financial performance
12.1.7.3 Product benchmarking
12.1.7.4 Strategic initiatives
12.1.8 SonaCare Medical LLC
12.1.8.1 Company overview
12.1.8.2 Financial performance
12.1.8.3 Product benchmarking
12.1.8.4 Strategic initiatives
12.1.9 Misonix Inc.
12.1.9.1 Company overview
12.1.9.2 Financial performance
12.1.9.3 Product benchmarking
12.1.9.4 Strategic initiatives
12.1.10 NeuWave Medical, Inc.
12.1.10.1 Company overview
12.1.10.2 Financial performance
12.1.10.3 Product benchmarking
12.1.10.4 Strategic initiatives
12.1.11 ERBE Elektromedizin GmbH
12.1.11.1 Company overview
12.1.11.2 Financial performance
12.1.11.3 Product benchmarking
12.1.12 Biotronik
12.1.12.1 Company overview
12.1.12.2 Financial performance
12.1.12.3 Product benchmarking

List of Tables

TABLE 1 North America tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 2 North America tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 3 North America tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 4 U.S. tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 5 U.S. tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 6 U.S. tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 7 Canada tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 8 Canada tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 9 Canada tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 10 Europe tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 11 Europe tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 12 Europe tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 13 U.K. tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 14 U.K. tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 15 U.K. tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 16 Germany tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 17 Germany tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 18 Germany tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 19 France tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 20 France tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 21 France tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 22 Italy tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 23 Italy tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 24 Italy tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 25 Spain tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 26 Spain tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 27 Spain tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 28 Belgium tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 29 Belgium tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 30 Belgium tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 31 Switzerland tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 32 Switzerland tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 33 Switzerland tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 34 Poland tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 35 Poland tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 36 Poland tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 37 Asia Pacific tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 38 Asia Pacific tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 39 Asia Pacific tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 40 China tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 41 China tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 42 China tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 43 Japan tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 44 Japan tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 45 Japan tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 46 Latin America tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 47 Latin America tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 48 Latin America tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 49 Brazil tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 50 Brazil tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 51 Brazil tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 52 Mexico tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 53 Mexico tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 54 Mexico tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 55 Middle East Asia tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 56 Middle East Asia tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 57 Middle East Asia tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 58 South Africa tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 59 South Africa tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 60 South Africa tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary 2016 (USD Million)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Increasing Purchasing Power Parity (PPP), USD , 2011 - 2014
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 15 Porter’s five forces analysis
FIG. 16 Tumor ablation market: Technology outlook key takeaways
FIG. 17 Tumor Ablation market: Technology movement analysis
FIG. 18 Global radiofrequency ablation market, 2014 - 2025 (USD Million)
FIG. 19 Global microwave market, 2014 - 2025 (USD Million)
FIG. 20 Global cryoablation market, 2014 - 2025 (USD Million)
FIG. 21 Global electroporation market, 2014 - 2025 (USD Million)
FIG. 22 Global other ablation technologies market, 2014 - 2025 (USD Million)
FIG. 23 Tumor ablation market: Treatment outlook key takeaways
FIG. 24 Tumor Ablation market: Treatment movement analysis
FIG. 25 Global surgical ablation market, 2014 - 2025 (USD Million)
FIG. 26 Global laparoscopic ablation market, 2014 - 2025 (USD Million)
FIG. 27 Global percutaneous ablation market, 2014 - 2025 (USD Million)
FIG. 28 Tumor ablation market: Application outlook key takeaways
FIG. 29 Tumor Ablation market: Application movement analysis
FIG. 30 Global liver cancer market, 2014 - 2025 (USD Million)
FIG. 31 Global breast cancer market, 2014 - 2025 (USD Million)
FIG. 32 Global lung cancer market, 2014 - 2025 (USD Million)
FIG. 33 Global prostate cancer market, 2014 - 2025 (USD Million)
FIG. 34 Global other cancer market, 2014 - 2025 (USD Million)
FIG. 35 Market share analysis, 2016
FIG. 36 Regional market place: Key takeaways
FIG. 37 Regional outlook, 2016 & 2025
FIG. 38 North America tumor ablation market, 2014 - 2025 (USD Million)
FIG. 39 U.S. Tumor ablation market, 2014 - 2025 (USD Million)
FIG. 40 Canada tumor ablation market, 2014 - 2025 (USD Million)
FIG. 41 Europe tumor ablation market, 2013 - 2024 (USD Million)
FIG. 42 U.K. tumor ablation market, 2013 - 2024 (USD Million)
FIG. 43 Germany tumor ablation market, 2014 - 2025 (USD Million)
FIG. 44 France tumor ablation market, 2014 - 2025 (USD Million)
FIG. 45 Italy tumor ablation market, 2014 - 2025 (USD Million)
FIG. 46 Spain tumor ablation market, 2014 - 2025 (USD Million)
FIG. 47 Belgium tumor ablation market, 2014 - 2025 (USD Million)
FIG. 48 Switzerland tumor ablation market, 2014 - 2025 (USD Million)
FIG. 49 Poland tumor ablation market, 2014 - 2025 (USD Million)
FIG. 50 Asia Pacific tumor ablation market, 2014 - 2025 (USD Million)
FIG. 51 Japan tumor ablation market, 2014 - 2025 (USD Million)
FIG. 52 China tumor ablation market, 2014 - 2025 (USD Million)
FIG. 53 Latin America tumor ablation market, 2014 - 2025 (USD Million)
FIG. 54 Brazil tumor ablation market, 2014 - 2025 (USD Million)
FIG. 55 Mexico tumor ablation market, 2014 - 2025 (USD Million)
FIG. 56 MEA tumor ablation market, 2014 - 2025 (USD Million)
FIG. 57 South Africa tumor ablation market, 2014 - 2025 (USD Million)
FIG. 58 Global company market share analysis 2017
FIG. 59 Regional market share analysis 2017
FIG. 60 Regional market share analysis 2017
FIG. 61 Regional market share analysis 2017
FIG. 62 Regional market share analysis 2017
FIG. 63 Regional market share analysis 2017
FIG. 64 Regional market share analysis 2017
FIG. 65 Strategy framework

【掲載企業】

Medtronic、AngioDynamics、Mermaid Medical、HealthTronics, Inc.、Galil Medical, Inc.、EDAP TMS、Boston Scientific Corporation、SonaCare Medical LLC、Misonix Inc.、NeuWave Medical, Inc.、ERBE Elektromedizin GmbH、Biotronik

★調査レポート[腫瘍アブレーションの世界市場:治療別(手術、経皮)、用途別(肺、肝臓癌)、技術別(高周波、マイクロ波)、セグメント予測] (コード:GVW903174)販売に関する免責事項を必ずご確認ください。
★調査レポート[腫瘍アブレーションの世界市場:治療別(手術、経皮)、用途別(肺、肝臓癌)、技術別(高周波、マイクロ波)、セグメント予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆